Abel Hall, LLC
- SEC CIK
- 0002013339
- Latest filing
- Jul 24, 2026
NVS holding history
Novartis AG in every 13F filed by Abel Hall, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 14,598
- Value
- $2.29M
- % of portfolio
- 0.4%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 14,598 | $2.29M | 0.4% | +99+0.7% | Added | Holders |
| Q1 2026 | 14,499 | $2.21M | 0.5% | +2,083+16.8% | Added | Holders |
| Q4 2025 | 12,416 | $1.71M | 0.4% | +7,523+153.8% | Added | Holders |
| Q3 2025 | 4,893 | $627.5K | 0.3% | +710+17.0% | Added | Holders |
| Q2 2025 | 4,183 | $506.2K | 0.2% | −531−11.3% | Reduced | Holders |
| Q1 2025 | 4,714 | $525.6K | 0.3% | +922+24.3% | Added | Holders |
| Q4 2024 | 3,792 | $369.0K | 0.2% | +82+2.2% | Added | Holders |
| Q3 2024 | 3,710 | $426.8K | 0.3% | +157+4.4% | Added | Holders |
| Q2 2024 | 3,553 | $378.3K | 0.3% | +351+11.0% | Added | Holders |
| Q1 2024 | 3,202 | $309.8K | 0.2% | +92+3.0% | Added | Holders |
| Q4 2023 | 3,110 | $314.1K | 0.3% | – | No prior filing | Holders |